Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chain reaction based DNA manufacturer, closed its previously announced registered direct offering with an institutional investor of 1.5 million shares of common stock at a price of $2.80 per share for gross proceeds of approximately $4.2 million, before deducting the placement agent’s fees and other offering expenses payable by the company. In a concurrent private placement, Applied DNA also issued to the institutional investor in the offering unregistered warrants to purchase up to an aggregate of 1.5 million shares of common stock.
Immediately following the closing of the registered direct offering and the concurrent private placement, the number of outstanding shares of common stock in the company will be 8.23 million.
